Informationen:
Fehler:
ID
28162
Beschreibung
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00642603
Link
https://clinicaltrials.gov/show/NCT00642603
Stichworte
Versionen (1)
- 22.12.17 22.12.17 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
22. Dezember 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Colorectal Cancer NCT00642603
Eligibility Colorectal Cancer NCT00642603
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Colorectal Cancer NCT00642603
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Adult | Age
Item
adult patients, ≥18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Adenocarcinoma of colon | Adenocarcinoma of rectum | Neoplasm Metastasis unresectable | Advanced disease Locally unresectable
Item
histologically confirmed adenocarcinoma of colon or rectum, with unresectable metastatic or locally advanced disease
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
C0027627 (UMLS CUI [3,1])
C1519810 (UMLS CUI [3,2])
C0679246 (UMLS CUI [4,1])
C1517927 (UMLS CUI [4,2])
C1519810 (UMLS CUI [4,3])
C0149978 (UMLS CUI [2])
C0027627 (UMLS CUI [3,1])
C1519810 (UMLS CUI [3,2])
C0679246 (UMLS CUI [4,1])
C1517927 (UMLS CUI [4,2])
C1519810 (UMLS CUI [4,3])
Target Lesion Measurable Quantity
Item
≥1 measurable target lesion
boolean
C2986546 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Ambulatory | ECOG performance status
Item
ambulatory, with an eastern cooperative oncology group (ecog) performance status of
boolean
C0439841 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C1520224 (UMLS CUI [2])
Systemic therapy Advanced disease | Systemic therapy Neoplasm Metastasis
Item
prior systemic therapy for advanced or metastatic disease
boolean
C1515119 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C0679246 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Cancer Other | Exception Basal cell carcinoma Cured | Exception Carcinoma in situ of uterine cervix Cured
Item
history of another malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of the cervix
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Warfarin Oral Dose Full | Anticoagulants Parenteral Dose Full | Thrombolytic Agents
Item
current or recent use of full dose oral warfarin or full dose parenteral anticoagulants or thrombolytic agents
boolean
C3216123 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0443225 (UMLS CUI [1,3])
C0003280 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0443225 (UMLS CUI [2,4])
C0016018 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0443225 (UMLS CUI [1,3])
C0003280 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0443225 (UMLS CUI [2,4])
C0016018 (UMLS CUI [3])
Aspirin U/day chronic
Item
chronic daily treatment with >325 mg/day aspirin
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])